Examine feasibility of aborting 22 week plus abnormal twin foetus: Delhi HC to AIIMS board
Justice Rekha Palli asked AIIMS to constitute a board, examine the woman and submit a report to the court by May 24 after the petitioner and her husband said that their doctors have said that after 24 weeks of gestation, abortion would not be advisable.
New Delhi: The Delhi High Court on Thursday asked the All India Institute of Medical Sciences (AIIMS) to set up a medical board to examine the feasibility and advisability of aborting the 22 week plus pregnancy examine of a woman whose twin foetus suffer from ''dandy walker malformation'', a rare congenital brain abnormality.
Justice Rekha Palli asked AIIMS to constitute a board, examine the woman and submit a report to the court by May 24 after the petitioner and her husband said that their doctors have said that after 24 weeks of gestation, abortion would not be advisable.
Also Read: Delhi HC permits Woman To terminate Over 24-Week Pregnancy
According to the petition, ''dandy walker malformation'' is a rare brain condition in which the part joining the two hemispheres of the cerebellum does not fully form.
The couple told the court that they initially found about the malformation on April 28, but their doctors wanted to confirm the diagnosis and that is why they took time to file a petition.
They also said that they did not know earlier that they would require a court order to abort a pregnancy which was at such an advanced stage and got to know about this only when the doctors said that an abortion can be carried out only on orders of a court.
The high court listed the matter for hearing on May 25.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.